Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Deutsche Bank AG (DB) vs Invesco Ltd. (IVZ) Price & Performance

Deutsche Bank AGTrade
Invesco Ltd.Trade

Price performance (Past 24H)

Key statistics

Deutsche Bank AG vs Invesco Ltd. — how do they compare? Deutsche Bank AG trades at $33.61 (market cap $63.13B), while Invesco Ltd. trades at $30.09 (market cap $13.47B). The key difference: Deutsche Bank AG is far larger — about 4.7× Invesco Ltd.'s market cap, and Deutsche Bank AG pays the higher dividend (3.47%). Which is the better fit depends on your goals — on Pluang, investors hold Deutsche Bank AG for 80 Days and Invesco Ltd. for 77 Days on average.

DBIVZ
Market Cap
$63.13B$13.47B
Volume
3,260,4884,447,526
Sector
FinancialsFinancials
52-Week High
$41.56$33.31
52-Week Low
$28.37$22.44
Typical Hold Time
80 Days77 Days
Enterprise Value
$75.71B$23.63B
Dividend Yield
3.47%2.82%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Deutsche Bank AG

Deutsche Bank (DB) trades at $33.63, down 4.27% amid a bearish technical signal. The stock shows attractive valuation with a P/E of 9.1 and P/B of 0.71, while recent earnings beat expectations in two of the last three quarters. Net income surged to $6.93B in 2025, though Q3 2026 investment bank revenue is expected flat to slightly down. Cash flow improved significantly with net cash flow of $7.61B in 2025.

The outlook is mixed: strong fundamentals and low valuation support upside, but bearish technicals and cautious analyst consensus (57.58% hold) indicate near-term headwinds. Key risks include revenue volatility in investment banking and macroeconomic sensitivity. The stock offers value potential if execution on 2028 targets holds.

Invesco Ltd.

Invesco (IVZ) trades at $30.09, down 0.95% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $281.70 million for 2025 despite revenue growth to $6.38 billion, with a negative net margin of -0.93%. Recent earnings have been mixed, beating in Q4 2025 and Q2 2026 but missing in Q1 2026, while Q3 2026 results are pending. Positive developments include strong operating cash flow of $1.53 billion in 2025 and the expansion of its QQQ ETF suite.

The outlook is cautiously optimistic, supported by a consensus price target of $33.71 and no sell ratings among analysts. Key opportunities lie in continued AUM growth and ETF innovation, but risks include profitability challenges and market volatility. The stock's current price near support at $30.00 suggests limited downside if fundamentals improve with upcoming earnings.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DB
100% Buy0% Sell
Avg holding period · 80 Days
IVZ

No sentiment data available yet.

Top news

Latest headlines on both assets

About Deutsche Bank AG

In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.

Read more on DB →

About Invesco Ltd.

Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).

Read more on IVZ →